Policy Insights
What is a Dormant GP practice, and why are they prescribing?
Science and Technology Select Committee Follows-Up on Trials Transparency
Goldacre Review outlines how to achieve better, broader, and safer use of health data for research and analysis
Better, Broader, Safer Uses of Data Help Data Saves Lives
Bennett Insights: An Overview of UK Data Policy Developments
National Data Guardian report cites and reinforces Bennett Institute work on building public trust in use of data for research
Making TREs the default across the NHS: A first step
How to get all trials reported: audit, better data, and individual accountability
Antivirals, pandemic planning, and failure to heed calls for trial data
Fixing flaws in science must be professionalized
A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
Noncommercial Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care
[PRE-PRINT] FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial results
Why researchers should share their analytic code
Barriers to Working With National Health Service England's Open Data
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
The poor performance of apps assessing skin cancer risk
Better use of data and digital offer rapid opportunities to address covid-19
Bringing NHS data analysis into the 21st century
The NHS deserves better use of hospital medicines data
